We also confirmed that miR-199a-5p significantly decreased the CD24-/CD44+ cell population (p = 0.0015) (Fig. 4d), which is a well-reported subpopulation of breast cancer cells to have stem/progenitor cell properties. The gene discussed is CD44; the disease is breast carcinoma.